Guillain & #8211;Barre syndrome after the first dose of Anti-SARS-CoV-2 vaccination is a rare side effect and the second jab is controversial in these cases

Anurug Biswas, Sanjay Kumar PandeyIndian Journal of Public Health 2022 66(4):535-536

https://www.ijph.in/text.asp?2022/66/4/535/366564

Source: Indian Journal of Public Health - December 31, 2022 Category: International Medicine & Public Health Authors: Anurug Biswas Sanjay Kumar Pandey Source Type: research

More News: Guillain-Barr Syndrome | India Health | International Medicine & Public Health | SARS | Vaccines